Lindbrook Capital, LLC - CARDLYTICS INC ownership

CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 167 filers reported holding CARDLYTICS INC in Q4 2021. The put-call ratio across all filers is 3.11 and the average weighting 0.6%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of CARDLYTICS INC
ValueSharesWeighting
Q3 2023$2,096127
+746.7%
0.00%
Q3 2022$0
-100.0%
15
-68.1%
0.00%
Q2 2022$1,000
-75.0%
47
-29.9%
0.00%
-100.0%
Q1 2022$4,000
+100.0%
67
+103.0%
0.00%
Q4 2021$2,000
-33.3%
330.0%0.00%
-100.0%
Q3 2021$3,000
-25.0%
330.0%0.00%0.0%
Q2 2021$4,0000.0%330.0%0.00%0.0%
Q1 2021$4,000
-20.0%
330.0%0.00%0.0%
Q4 2020$5,000
+150.0%
330.0%0.00%0.0%
Q3 2020$2,0000.0%330.0%0.00%0.0%
Q2 2020$2,000330.00%
Other shareholders
CARDLYTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
CAS Investment Partners, LLC 2,821,710$177,373,00029.17%
Antipodean Advisors LLC 656,000$41,236,00023.59%
BRIGHTLIGHT CAPITAL MANAGEMENT LP 272,900$17,154,00012.97%
Oakcliff Capital Partners, LP 281,064$17,668,00010.54%
Polaris Venture Management Co. V, L.L.C. 200,000$12,572,0009.14%
Covey Capital Advisors, LLC 82,947$5,214,0005.63%
683 Capital Management, LLC 575,000$36,145,0004.13%
JS Capital Management LLC 455,000$28,601,0003.30%
CROSSLINK CAPITAL INC 152,086$9,560,0002.17%
Pier Capital, LLC 125,692$7,901,0001.29%
View complete list of CARDLYTICS INC shareholders